ロード中...
Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective agent used in conjunction with anthracycline therapy. There i...
保存先:
| 出版年: | Leuk Res Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5402627/ https://ncbi.nlm.nih.gov/pubmed/28462084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2017.04.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|